Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Clinics ; 68(4): 557-562, abr. 2013. tab, graf
Article Dans Anglais | LILACS | ID: lil-674244

Résumé

OBJECTIVES: Chemical pleurodesis is an important therapeutic tool to control recurrent malignant pleural effusion. Among the various sclerosing agents, iodopovidone is considered effective and safe. However, in a recent study, ocular changes were described after iodopovidone was used in recurrent pneumothorax. The aim of the study was to evaluate the efficacy and morbidity of iodopovidone pleurodesis in an experimental model. METHODS: New Zealand rabbits were submitted to intrapleural injection of iodopovidone at concentrations of 2%, 4% and 10%. Biochemical (lactic dehydrogenase, proteins, triiodothyronine, free thyroxine, urea and creatinine) and immunological (Interleukin-8 [IL-8], VEGF and TGFβ) parameters were measured in the pleural fluid and blood. After 1, 3, 7, 14 and 28 days, groups of animals were euthanized, and macro- (pleura) and microscopic (pleura and retina) analyses were performed. RESULTS: An early pleural inflammatory response with low systemic repercussion was observed without corresponding changes in thyroid or renal function. The higher concentrations (4% and 10%) correlated with greater initial exudation, and maximum pleural thickening was observed after 28 days. No changes were observed in the retinal pigment epithelium of the rabbits. CONCLUSION: Iodopovidone is considered to be an effective and safe sclerosing agent in this animal model. However, its efficacy, tolerance and safety in humans should be further evaluated. .


Sujets)
Animaux , Lapins , Épanchement pleural malin/thérapie , Pleurodèse/méthodes , Povidone iodée/administration et posologie , Solutions sclérosantes/administration et posologie , Cytokines/sang , Test ELISA , Modèles animaux , Plèvre/effets des médicaments et des substances chimiques , Povidone iodée/effets indésirables , Épithélium pigmentaire de la rétine/effets des médicaments et des substances chimiques , Solutions sclérosantes/effets indésirables , Facteurs temps
2.
Clinics ; 67(11): 1259-1263, Nov. 2012. ilus, tab
Article Dans Anglais | LILACS | ID: lil-656714

Résumé

OBJECTIVE: Pleural tuberculosis is the most frequently occurring form of extra pulmonary disease in adults. In up to 40% of cases, the lung parenchyma is concomitantly involved, which can have an epidemiological impact. This study aims to evaluate the pleural and systemic inflammatory response of patients with pleural or pleuropulmonary tuberculosis. METHODS: A prospective study of 39 patients with confirmed pleural tuberculosis. After thoracentesis, a high resolution chest tomography was performed to evaluate the pulmonary involvement. Of the 39 patients, 20 exhibited only pleural effusion, and high resolution chest tomography revealed active associated-pulmonary disease in 19 patients. The total protein, lactic dehydrogenase, adenosine deaminase, vascular endothelial growth factor, interleukin-8, tumor necrosis factor-α, and transforming growth factor-β1 levels were quantified in the patient serum and pleural fluid. RESULTS: All of the effusions were exudates with high levels of adenosine deaminase. The levels of vascular endothelial growth factor and transforming growth factor-β1 were increased in the blood and pleural fluid of all of the patients with pleural tuberculosis, with no differences between the two forms of tuberculosis. The tumor necrosis factor-α levels were significantly higher in the pleural fluid of the patients with the pleuropulmonary form of tuberculosis. The interleukin-8 levels were high in the pleural fluid of all of the patients, without any differences between the forms of tuberculosis. CONCLUSION: Tumor necrosis factor-α was the single cytokine that significantly increased in the pleural fluid of the patients with pulmonary involvement. However, an overlap in the results does not permit us to suggest that cytokine is a biological marker of concomitant parenchymal involvement. Although high resolution chest tomography can be useful in identifying these patients, the investigation of fast acid bacilli and cultures for M. tuberculosis in the sputum is recommended for all patients who are diagnosed with pleural tuberculosis.


Sujets)
Adulte , Humains , Adulte d'âge moyen , Jeune adulte , Marqueurs biologiques/analyse , Épanchement pleural/métabolisme , Tuberculose pleurale/métabolisme , Adenosine deaminase/analyse , Cytokines/analyse , Évolution de la maladie , Test ELISA , Exsudats et transsudats/composition chimique , Oxidoreductases/analyse , Études prospectives , Épanchement pleural , Facteur de croissance transformant bêta-1/analyse , Tuberculose pleurale , Tuberculose pulmonaire/métabolisme , Facteur de nécrose tumorale alpha/analyse , Facteur de croissance endothéliale vasculaire de type A/analyse
SÉLECTION CITATIONS
Détails de la recherche